Nearly a hundred days into his second term, the Hearst Television Data Team analyzed movements in inflation and the stock ...

Wall Street is showing a mixed performance on Monday as investors prepare for a busy week ahead, filled with significant ...

President Donald Trump could be setting up Fed Chair Jerome Powell as a 'scapegoat' if a recession hits, according to an MSU ...

A report Friday said sentiment among U.S. consumers sank in April, though not by as much as economists expected. The survey ...

The stock and bond markets are awaiting news on trade deals as the Dow, S&P 500 and Nasdaq Composite look to build on last ...

Attom's property-tax numbers are the latest high-level look at a growing issue for homeowners, prospective home buyers and politicians that comes as home values, along with costs for local services, ...

It's getting more and more expensive to check a bag when you fly.

As the tariff wars continue to unfold, the markets are attempting to kick off the week with gains as the latest slew of tech ...

Investors hope for more progress on tariff deals. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

It's only been a half-hour, but the stock market has already fumbled its early gains. The Nasdaq Composite was down 0.4% in early Monday trading. The S&P 500 was down 0.1%. The Dow, which minutes ago ...

The S&P 500 and the Dow inched higher in choppy trading on Monday as investors braced for a week packed with key economic ...

Alnylam Pharmaceuticals said its RNAi therapeutic vutrisiran received a positive opinion recommending approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency.